Addressing Healthcare Inequities in Cardiac Amyloidosis: Interventions Aimed at Improving Care for All Patients
November 30, 2022
November 30, 2023
Scroll to the Bottom of this Information to Begin this Course
This activity is provided by Physicians’ Education Resource®, LLC.
This activity is supported by an educational grant from Pfizer Inc.
- Physicians — maximum of 1.0 AMA PRA Category 1 Credits™
- Nurses — 1.0 Contact Hours
All other healthcare professionals completing this course will be issued a statement of participation.
This educational activity is primarily directed toward cardiologists, heart failure specialists, heart failure nurses, neurologists, echocardiographers, nuclear cardiologists, primary care clinicians, NPs and PAs. Other HCPs involved in the diagnosis and management of ATTR-CM are also invited to participate.
Addressing Healthcare Inequities is a video-based program in which 3 experts discuss health disparities that negatively impact patients with cardiac amyloidosis. Access to care, insurance costs, and unintended bias are just some of the factors that contribute to the existence and persistence of these disparities. This engaging format is designed to help clinicians better recognize and take steps to address ethnic and racial disparities in cardiac amyloidosis, thereby forwarding progress to improve patient outcomes.
- Upon successful completion of this activity, you should be better prepared to:
- Identify the barriers contributing to the geographic and racial healthcare disparities in cardiac amyloidosis (ATTR-CM) care
- Determine the role of genetic variabilities commonly seen in patients with ATTR-CM
- Review strategies facilitating a diagnosis early in the disease course of ATTR-CM across all racial groups
- Apply best practices to improve access to quality ATTR-CM care
Kevin M. Alexander, MD, FACC, FHFSA
Assistant Professor of Medicine
Division of Cardiovascular Medicine
Stanford Cardiovascular Institute
Stanford Amyloid Center
Stanford University School of Medicine
Palo Alto, CA
Sarah Cuddy, MB, BCh, BAO
Instructor, Harvard Medical School
Cardiologist, Brigham Amyloidosis Program
Brigham and Women’s Hospital
Ahmad Masri, MD, MS
Director, Cardiac Amyloidosis Program
Director, Hypertrophic Cardiomyopathy Center
Assistant Professor of Medicine
Division of Cardiology
Oregon Health & Science University
Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.0 Contact Hours.
Faculty, Staff, and Planners’ Disclosures
The staff of Physicians’ Education Resource®, LLC have no relevant financial relationships with ineligible entities.
- Kevin M. Alexander, MD, FACC, FHFSA
- Grant/Research Support: Alnylam, Eidos, Ionis, Janssen
- Consultant: Alnylam, Arbor Biotechnologies, Eidos, Ionis, Novo Nordisk, Pfizer
- Sarah Cuddy, MB, BCh, BAO
- Grant/Research Support: Pfizer
- Consultant: AstraZeneca, Novo Nordisk
- Speaker’s Bureau: BridgeBio, Ionis, Pfizer
- Ahmad Masri, MD, MS
- Grant/Research Support: Akcea, Ionis, Pfizer, The Wheeler Foundation, Ultromics
- Consultant: Attralus, Bristol Myers Squibb, Cytokinetics, Eidos, Intellia, Ionis, Tenaya
PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.
Instructions for Participation and Credit
- Complete the activity (including pre- and post-activity assessments).
- Answer the evaluation questions.
- Request credit using the drop-down menu.
Course Viewing Requirements
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
Off-Label Disclosure and Disclaimer
This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.